JoVE Logo

Sign In

A Rapid Screening Workflow to Identify Potential Combination Therapy for GBM using Patient-Derived Glioma Stem Cells

2.6K Views

05:29 min

March 28th, 2021

DOI :

10.3791/62312-v

March 28th, 2021

2,571 Views

1Department of Cell Biology, School of Basic Medical Sciences, Nanjing Medical University, 2Institute for Brain Tumors & Key Laboratory of Rare Metabolic Diseases, Nanjing Medical University; Nanjing Medical University Affiliated Cancer Hospital; Key Laboratory of Human Functional Genomics of Jiangsu Province

Transcript

Explore More Videos

Keywords Glioma Stem Cells
JoVE Logo

Privacy

Terms of Use

Policies

Research

Education

ABOUT JoVE

Copyright © 2024 MyJoVE Corporation. All rights reserved